Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

High-Dose Ibuprofen, COX-2s Show Similar Vascular Event Risk, BMJ Study Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Researchers found no significant difference in vascular events between COX-2s, NSAIDs overall in British Medical Journal report.

You may also be interested in...



American Liver Foundation Issues Warning On Acetaminophen Intake Levels

Advisory follows recent JAMA study finding that maximum recommended OTC intake resulted in elevated liver enzymes for some participants.

NAD Says Pure Power “Number One” Claim Based On IRI Data Is “Flawed”

Worldwide Sport Nutritional Supplements' use of the claim "America's Decided! We're Number One!" for its Pure Power Protein Bars is "flawed" and unsubstantiated, the National Advertising Division states in an upcoming issue of Case Reports

NPA’s TruLabel Program Expands To Ensure Purity Of Sports Supplements

The Natural Products Association is expanding testing in its TruLabel verification program to assure consumers that the products "are without traces of banned steroidal and stimulant ingredients.

Topics

UsernamePublicRestriction

Register

OM017181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel